Transforming Evidence
into Practice

1. The submitted paper should not have been published elsewhere or currently under review.

2. Studies should have obtained ethics approval and should be able to submit if requested.

3. Structure of the paper

• Components: Abstract, Introduction, Methods, Results, Discussion (without subheadings), Acknowledgement, Conflict of interest, References.
• Title: Capitalize only first word and proper nouns. Max 150 characters.
• Author surnames followed by initial(s).
• Affiliations with superscript Arabic numerals. Underline corresponding author.
• Abstract: Abstract text is limited to a maximum of 250 words, structured: Background & objective, Methods, Results, Conclusions. Keywords not exceeding 5.
• Main text: 1000–1500 words (excl. abstract).
• Tables/figures: Editable format, numbered, table heading above, figure caption below.

4. References:

• References should be listed and cited as per Vancouver referencing style.
• Number of references is 10-15.

5. Please keep the acknowledgment brief.

6. All authors declare conflict of interest.

7. Format: MS Word, Times New Roman, 12pt, single spacing, title bold, affiliations 10pt italics. All the pages should be numbered.

8. The manuscript should be submitted electronically to the following email: rcfmjabs@univ.jfn.ac.lk

The scientific committee of the RCFMJ 2026 will communicate only with the corresponding author.
The corresponding author is responsible for informing the comments and decisions on the manuscript to co-authors and providing correct information of the co-authors (names, affiliations, and conflicts of interest).

9. If the paper is accepted

• The corresponding author or one of the co-authors available to present the paper at the conference.
• The presenting author should register for the conference.
• Manuscript may be subjected to language editing to improve the presentation.

10. You may be an author for more than one paper. However, one author can present maximum two papers at the free paper sessions.